Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B

Published:2020-04-30 Issue:7 Volume:40 Page:1578-1589
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Ogawa Eiichi¹^ORCID,Nomura Hideyuki²³,Nakamuta Makoto⁴,Furusyo Norihiro¹,Koyanagi Toshimasa⁵,Dohmen Kazufumi⁶,Ooho Aritsune⁷,Satoh Takeaki⁸,Kawano Akira⁹,Kajiwara Eiji¹⁰,Takahashi Kazuhiro¹¹,Azuma Koichi¹²,Kato Masaki¹³,Shimoda Shinji¹⁴,Hayashi Jun¹⁵,

Affiliation:

1. Department of General Internal Medicine Kyushu University Hospital Fukuoka Japan

2. The Center for Liver Disease Shin‐Kokura Hospital Kitakyushu Japan

3. Department of Medicine Haradoi Hospital Fukuoka Japan

4. Department of Gastroenterology Kyushu Medical Center National Hospital Organization Fukuoka Japan

5. Department of Medicine Fukuoka City Hospital Fukuoka Japan

6. Department of Internal Medicine Chihaya Hospital Fukuoka Japan

7. Department of Hepatology Steel Memorial Yawata Hospital Kitakyushu Japan

8. Center for Liver Disease Kokura Medical Center Kitakyushu Japan

9. Department of Medicine Kitakyushu Municipal Medical Center Kitakyushu Japan

10. Kajiwara Clinic Kitakyushu Japan

11. Department of Medicine Hamanomachi Hospital Fukuoka Japan

12. Department of Medicine Kyushu Central Hospital Fukuoka Japan

13. Department of Medicine and Bioregulatory Science Graduate School of Medical Sciences Kyushu University Fukuoka Japan

14. Department of Medicine and Biosystemic Science Graduate School of Medical Sciences Kyushu University Fukuoka Japan

15. Kyushu General Internal Medicine Center Haradoi Hospital Fukuoka Japan

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14482

Reference35 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

2. Viral hepatitis B

3. Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

4. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

5. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel protocol for prevention from hepatitis B reactivation following living‐donor liver transplantation;Hepatology Research;2024-09-14

2. Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates;2024-06-25

3. Evaluation of clinical characteristics and treatment patterns of patients infected with hepatitis B;Journal of Medicine and Palliative Care;2024-02-29

4. Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world multicenter cohort study;Hepatology Research;2024-02

5. Multiple Low-level Viremia Suggest Hindered Liver Fibrosis Regression in Chronic Hepatitis B Patients during Antiviral Therapy;2024-01-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3